Good News: Opioid Prescribing Fell. The Bad? Pain Patients Suffer, Doctors Say. - The New York Times

Good News: Opioid Prescribing Fell. The Bad? Pain Patients Suffer, Doctors Say. - The New York Times

More reads

• Patient group asks BIO to denounce Catalyst over the $375,000 price of its rare disease drug. (STAT Plus)
• Clinicians embracing new depression drug esketamine with ‘enthusiastic caution.’ (STAT)
• Beam brings in $135 million to turn CRISPR base editing into drugs. (Xconomy)
• Good news: Opioid prescribing fell. The bad? Pain patients suffer, doctors say. (New York Times)